Structure-Based Molecular Docking Study of a Designed Cationic Peptide Sequence KRLVAGLIRKLA Against Targeting the Extracellular Domain of HER2 in HER2-Positive Breast Cancer. AMAR [Internet]. 2026 Mar. 21 [cited 2026 Oct. 18];4(3):985-1101. Available from: https://www.amresearchjournal.com/index.php/Journal/article/view/2536